Shopping Cart 0
Cart Subtotal
USD 0

Global Self-monitoring Blood Glucose Devices Market (2018-2023)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 2950

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 2950

Details

The self-monitoring blood glucose devices market comprises testing strips, glucometers and other product segments such as lancets and lancing devices. Increase in aging population, high prevalence of diabetes due to unhealthy lifestyle, poor diet, excess alcohol consumption, and lack of physical activity, creates a huge demand for blood glucose devices across the globe. The global self-monitoring blood glucose devices market is forecast to grow at a CAGR of 4.8% (2018-2023) and will reach USD 9.4 Bn in 2023 from USD 7.4 Bn in 2018. Market players are primarily focusing on product launches, and mergers and acquisitions to broaden their customer base, as well as to consolidate their position in the market.

Segmentation based on product type

Based on product type, in 2018, the testing strips segment contributed the highest market share (78.8%), on account of its economical pricing in comparison to glucose meters, and awareness among diabetes patients. The glucometers segment was the second-largest segment, with a market share of 16.1%, owing to its ease of use, painless procedure, and quick results.

The other products' segment comprises lancets, lancing devices etc. It accounted for a 5.1% share of the market, and is expected to show moderate growth during the forecast period

Segmentation based on end user type

Based on end user type, the market is segmented into hospitals, home settings, and diagnostics centers and clinics. Home settings segment contributed the highest market share of 86.7% in 2018 and will continue to grow at CAGR 4.9% due to convenience as these devices allow patients to check their blood glucose levels at home, at their own convenience.

During the forecast period, diagnostic centres and clinics are expected to expand at a moderate growth rate; in 2018, the segment witnessed market share of 8.5%. In 2018, hospital segment demonstrated least market share of 4.7%; the segment is projected to expand at a nominal growth in the coming years.

Regional insights

The self-monitoring blood glucose devices market in North America accounted for highest market share of 39.8% in 2018. The segment is expected to increase at CAGR 4.2% from 2018-2023 owing to factors such as growing number of advanced medical facilities, rising healthcare expenditure, and favourable reimbursement policies in the region. In 2018, testing strips segment contributed the highest revenue in North America region due to increase in diabetes cases, increasing disposable income, and technological advancements. The European market is anticipated to expand at a CAGR of 4.6% during the forecast period, given the presence of major market players in the region, improved awareness, and availability of self-monitoring blood glucose devices in a number of variants.

A large population, higher disposable income, and improved awareness about self-monitoring blood glucose devices will help the Asia-Pacific region dominate the global market during the forecast period. The Middle East and Africa and the Latin America markets, though still at nascent stages, will also experience high growth

Companies covered

Roche Holding AG

LifeScan, Inc.

Abbott Laboratories

Ypsomed AG

B. Braun Melsungen AG

Ascensia Diabetes Care

DiaMonTech

Nemaura Medical Inc.

Noviosense BV

READ MORE

Table Of Content

Scope

Chapter 1: Executive summary

1.1. Market scope and segmentation

1.2. Key questions answered in the study

1.3. Executive summary

Chapter 2: Introduction

2.1. Market definitions

2.2. Global market trends

2.3. Global drivers

2.4. Global challenges

2.5. Revenue based on product type-2018 (USD Bn)

2.6. Revenue based on end user type-2018 (USD Bn)

2.7. Value chain of self-monitoring blood glucose devices market

Chapter 3: Global Self-monitoring Blood Glucose Devices Market Overview

3.1. Market overview

3.1.a. Global market revenue-(2015-2017) (USD Bn)

3.1.b. Global forecast market revenue-(2018-2023) (USD Bn)

3.1.c. Geography-wise market revenue-(2018, 2023) (USD Bn)

Chapter 4: Global Self-monitoring Blood Glucose Devices Market-Segment Insights

4.1. Global testing strips market

4.1.a. Revenue-(2015-2023) (USD Bn)

4.1.b. Trends

4.1.c. Drivers

4.2. Global glucometers market

4.2.a. Revenue-(2015-2023) (USD Bn)

4.2.b. Trends

4.2.c. Drivers

4.3. Global other product segments market

4.3.a. Revenue-(2015-2023) (USD Bn)

4.3.b. Trends

4.3.c. Drivers

Chapter 5: Global Self-monitoring Blood Glucose Devices Market-Based on Regions

5.1. North America

5.1.a. Overview

5.1.b. Revenue-(2015-2023) (USD Bn)

5.1.c. Key Highlights

5.2. Europe

5.2.a. Overview

5.2.b. Revenue-(2015-2023) (USD Bn)

5.2.c. Key Highlights

5.3. Asia-Pacific

5.3.a. Overview

5.3.b. Revenue-(2015-2023) (USD Bn)

5.3.c. Key Highlights

5.4. The Middle Esat and Africa

5.4.a. Overview

5.4.b. Revenue-(2015-2023) (USD Bn)

5.4.c. Key Highlights

5.5. Latin America

5.4.a. Overview

5.4.b. Revenue-(2015-2023) (USD Bn)

5.4.c. Key Highlights

Chapter 6: Market Share of Companies

6.1. Global self-monitoring blood glucose devices market share of companies

6.1.a. Overview

Chapter 7: Competitive Landscape

7.1. Roche Holding AG

7.1.a. Company snapshot

7.1.b. Products

7.1.c. Initiatives

7.1.d. Growth strategy

Note: Similar information areas will be covered for the remaining competitors

7.2. LifeScan, Inc.

7.3. Abbott Laboratories

7.4. Ypsomed AG

7.5. B. Braun Melsungen AG

Chapter 8: Self-monitoring Blood Glucose Devices Start-up Firms

8.1. Ascensia Diabetes Care

8.2. DiaMonTech

8.3. Nemaura Medical Inc.

8.4. Noviosense BV

Chapter 9: Conclusion

Chapter 10: Appendix

10.1. List of tables

10.2. Research methodology

10.3. About Research on Global Markets

10.4. Disclaimer

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Global Self-monitoring Blood Glucose Devices Market, Global Self-monitoring Blood Glucose Devices market segments, Type-wise segmentation of the Global Self-monitoring Blood Glucose Devices market, Self-monitoring Blood Glucose Devices Market research report, Self-monitoring Blood Glucose Devices market, Global Self-monitoring Blood Glucose Devices Market research report, End-user wise segmentation of the Global Self-monitoring Blood Glucose Devices Market, Global Self-monitoring Blood Glucose Devices Market Size, Global Self-monitoring Blood Glucose Devices Market forecast, Self-monitoring Blood Glucose Devices Market forecast, Global Self-monitoring Blood Glucose Devices Market growth, Self-monitoring Blood Glucose Devices Market growth, Region-wise Segmentation of the Global Self-monitoring Blood Glucose Devices Market, Global Self-monitoring Blood Glucose Devices Market Revenue, Region-wise Segmentation of Global Self-monitoring Blood Glucose Devices Market, Global Self-monitoring Blood Glucose Devices industry analysis, Self-monitoring Blood Glucose Devices industry analysis, Global Self-monitoring Blood Glucose Devices Market statistics, Global Self-monitoring Blood Glucose Devices Market segmentation, key trends in the Global Self-monitoring Blood Glucose Devices market, Global Self-monitoring Blood Glucose Devices market major companies, Company profiles of Self-monitoring Blood Glucose Devices companies in Global, Major companies operating in the Global Self-monitoring Blood Glucose Devices Market,Global Self-monitoring Blood Glucose Devices Market, Self-monitoring Blood Glucose Devices Market, Self-monitoring Blood Glucose Devices Market Research, Global Self-monitoring Blood Glucose Devices Market Size


Companies

1. Roche Holding AG

2. LifeScan, Inc.

3. Abbott Laboratories

4. Ypsomed AG

5. B. Braun Melsungen AG

6. Ascensia Diabetes Care

7. DiaMonTech

8. Nemaura Medical Inc.

9. Noviosense BV

Company Profile

Company Profile Title

The self-monitoring blood glucose devices market comprises testing strips, glucometers and other product segments such as lancets and lancing devices. Increase in aging population, high prevalence of diabetes due to unhealthy lifestyle, poor diet, excess alcohol consumption, and lack of physical activity, creates a huge demand for blood glucose devices across the globe. The global self-monitoring blood glucose devices market is forecast to grow at a CAGR of 4.8% (2018-2023) and will reach USD 9.4 Bn in 2023 from USD 7.4 Bn in 2018. Market players are primarily focusing on product launches, and mergers and acquisitions to broaden their customer base, as well as to consolidate their position in the market.

Segmentation based on product type

Based on product type, in 2018, the testing strips segment contributed the highest market share (78.8%), on account of its economical pricing in comparison to glucose meters, and awareness among diabetes patients. The glucometers segment was the second-largest segment, with a market share of 16.1%, owing to its ease of use, painless procedure, and quick results.

The other products' segment comprises lancets, lancing devices etc. It accounted for a 5.1% share of the market, and is expected to show moderate growth during the forecast period

Segmentation based on end user type

Based on end user type, the market is segmented into hospitals, home settings, and diagnostics centers and clinics. Home settings segment contributed the highest market share of 86.7% in 2018 and will continue to grow at CAGR 4.9% due to convenience as these devices allow patients to check their blood glucose levels at home, at their own convenience.

During the forecast period, diagnostic centres and clinics are expected to expand at a moderate growth rate; in 2018, the segment witnessed market share of 8.5%. In 2018, hospital segment demonstrated least market share of 4.7%; the segment is projected to expand at a nominal growth in the coming years.

Regional insights

The self-monitoring blood glucose devices market in North America accounted for highest market share of 39.8% in 2018. The segment is expected to increase at CAGR 4.2% from 2018-2023 owing to factors such as growing number of advanced medical facilities, rising healthcare expenditure, and favourable reimbursement policies in the region. In 2018, testing strips segment contributed the highest revenue in North America region due to increase in diabetes cases, increasing disposable income, and technological advancements. The European market is anticipated to expand at a CAGR of 4.6% during the forecast period, given the presence of major market players in the region, improved awareness, and availability of self-monitoring blood glucose devices in a number of variants.

A large population, higher disposable income, and improved awareness about self-monitoring blood glucose devices will help the Asia-Pacific region dominate the global market during the forecast period. The Middle East and Africa and the Latin America markets, though still at nascent stages, will also experience high growth

Companies covered

Roche Holding AG

LifeScan, Inc.

Abbott Laboratories

Ypsomed AG

B. Braun Melsungen AG

Ascensia Diabetes Care

DiaMonTech

Nemaura Medical Inc.

Noviosense BV

READ MORE

Scope

Chapter 1: Executive summary

1.1. Market scope and segmentation

1.2. Key questions answered in the study

1.3. Executive summary

Chapter 2: Introduction

2.1. Market definitions

2.2. Global market trends

2.3. Global drivers

2.4. Global challenges

2.5. Revenue based on product type-2018 (USD Bn)

2.6. Revenue based on end user type-2018 (USD Bn)

2.7. Value chain of self-monitoring blood glucose devices market

Chapter 3: Global Self-monitoring Blood Glucose Devices Market Overview

3.1. Market overview

3.1.a. Global market revenue-(2015-2017) (USD Bn)

3.1.b. Global forecast market revenue-(2018-2023) (USD Bn)

3.1.c. Geography-wise market revenue-(2018, 2023) (USD Bn)

Chapter 4: Global Self-monitoring Blood Glucose Devices Market-Segment Insights

4.1. Global testing strips market

4.1.a. Revenue-(2015-2023) (USD Bn)

4.1.b. Trends

4.1.c. Drivers

4.2. Global glucometers market

4.2.a. Revenue-(2015-2023) (USD Bn)

4.2.b. Trends

4.2.c. Drivers

4.3. Global other product segments market

4.3.a. Revenue-(2015-2023) (USD Bn)

4.3.b. Trends

4.3.c. Drivers

Chapter 5: Global Self-monitoring Blood Glucose Devices Market-Based on Regions

5.1. North America

5.1.a. Overview

5.1.b. Revenue-(2015-2023) (USD Bn)

5.1.c. Key Highlights

5.2. Europe

5.2.a. Overview

5.2.b. Revenue-(2015-2023) (USD Bn)

5.2.c. Key Highlights

5.3. Asia-Pacific

5.3.a. Overview

5.3.b. Revenue-(2015-2023) (USD Bn)

5.3.c. Key Highlights

5.4. The Middle Esat and Africa

5.4.a. Overview

5.4.b. Revenue-(2015-2023) (USD Bn)

5.4.c. Key Highlights

5.5. Latin America

5.4.a. Overview

5.4.b. Revenue-(2015-2023) (USD Bn)

5.4.c. Key Highlights

Chapter 6: Market Share of Companies

6.1. Global self-monitoring blood glucose devices market share of companies

6.1.a. Overview

Chapter 7: Competitive Landscape

7.1. Roche Holding AG

7.1.a. Company snapshot

7.1.b. Products

7.1.c. Initiatives

7.1.d. Growth strategy

Note: Similar information areas will be covered for the remaining competitors

7.2. LifeScan, Inc.

7.3. Abbott Laboratories

7.4. Ypsomed AG

7.5. B. Braun Melsungen AG

Chapter 8: Self-monitoring Blood Glucose Devices Start-up Firms

8.1. Ascensia Diabetes Care

8.2. DiaMonTech

8.3. Nemaura Medical Inc.

8.4. Noviosense BV

Chapter 9: Conclusion

Chapter 10: Appendix

10.1. List of tables

10.2. Research methodology

10.3. About Research on Global Markets

10.4. Disclaimer

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Global Self-monitoring Blood Glucose Devices Market, Global Self-monitoring Blood Glucose Devices market segments, Type-wise segmentation of the Global Self-monitoring Blood Glucose Devices market, Self-monitoring Blood Glucose Devices Market research report, Self-monitoring Blood Glucose Devices market, Global Self-monitoring Blood Glucose Devices Market research report, End-user wise segmentation of the Global Self-monitoring Blood Glucose Devices Market, Global Self-monitoring Blood Glucose Devices Market Size, Global Self-monitoring Blood Glucose Devices Market forecast, Self-monitoring Blood Glucose Devices Market forecast, Global Self-monitoring Blood Glucose Devices Market growth, Self-monitoring Blood Glucose Devices Market growth, Region-wise Segmentation of the Global Self-monitoring Blood Glucose Devices Market, Global Self-monitoring Blood Glucose Devices Market Revenue, Region-wise Segmentation of Global Self-monitoring Blood Glucose Devices Market, Global Self-monitoring Blood Glucose Devices industry analysis, Self-monitoring Blood Glucose Devices industry analysis, Global Self-monitoring Blood Glucose Devices Market statistics, Global Self-monitoring Blood Glucose Devices Market segmentation, key trends in the Global Self-monitoring Blood Glucose Devices market, Global Self-monitoring Blood Glucose Devices market major companies, Company profiles of Self-monitoring Blood Glucose Devices companies in Global, Major companies operating in the Global Self-monitoring Blood Glucose Devices Market,Global Self-monitoring Blood Glucose Devices Market, Self-monitoring Blood Glucose Devices Market, Self-monitoring Blood Glucose Devices Market Research, Global Self-monitoring Blood Glucose Devices Market Size


Companies

1. Roche Holding AG

2. LifeScan, Inc.

3. Abbott Laboratories

4. Ypsomed AG

5. B. Braun Melsungen AG

6. Ascensia Diabetes Care

7. DiaMonTech

8. Nemaura Medical Inc.

9. Noviosense BV